Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6150
+0.0350 (2.22%)
NASDAQ · Last Trade: Mar 31st, 11:52 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors